Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma
Corresponding Author
Centre Méditerranéen de Médecine Moléculaire (C3M), Université Nice Côte d'Azur, INSERM, Nice, France
Department of Dermatology, Université Nice Côte d'Azur, CHU Nice, Nice, France
*Equally contributing, co-first and co-last authors
Correspondence
Dr Henri Montaudié, MD, PhD, Department of Dermatology and C3M INSERM U1065, 151 route Saint-Antoine de Ginestière, 06200 Nice, France.
Email: montaudie.h@chu-nice.fr
Search for more papers by this author
Comments (0)